Neuroproteomics as a promising tool in Parkinson’s disease research
- First Online:
- Cite this article as:
- Pienaar, I.S., Daniels, W.M.U. & Götz, J. J Neural Transm (2008) 115: 1413. doi:10.1007/s00702-008-0070-3
- 120 Downloads
Despite the vast number of studies on Parkinson’s disease (PD), its effective diagnosis and treatment remains unsatisfactory. Hence, the relentless search for an optimal cure continues. The emergence of neuroproteomics, with its sophisticated techniques and non-biased ability to quantify proteins, provides a methodology with which to study the changes in neurons that are associated with neurodegeneration. Neuroproteomics is an emerging tool to establish disease-associated protein profiles, while also generating a greater understanding as to how these proteins interact and undergo post-translational modifications. Furthermore, due to the advances made in bioinformatics, insight is created concerning their functional characteristics. In this review, we first summarize the most prominent proteomics techniques and then discuss the major advances in the fast-growing field of neuroproteomics in PD. Ultimately, it is hoped that the application of this technology will lead towards a presymptomatic diagnosis of PD, and the identification of risk factors and new therapeutic targets at which pharmacological intervention can be aimed.
KeywordsAlzheimer’s disease Biomarker Cerebrospinal fluid Mass spectrometry Neurodegenerative disease Neuroproteomics Parkinson’s disease
Substantia Nigra pars compacta